Lewinter Christian, Bland John M, Crouch Simon, Doherty Patrick, Lewin Robert J, Køber Lars, Hall Alistair S, Gale Christopher P
Department of Health Science, University of York, UK.
Eur J Prev Cardiol. 2014 Feb;21(2):163-71. doi: 10.1177/2047487312469124. Epub 2012 Nov 22.
International guidelines recommend referral for cardiac rehabilitation (CR) after acute myocardial infarction (AMI). However, the impact on long-term survival after CR referral has not been adjusted by time-variance. We compared the effects of CR referral after hospitalization for AMI in two consecutive decades.
A total of 2196 and 2055 patients were recruited in the prospective observational studies of the Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) -1 and 2 in 1995 and 2003, (1995: median age 72 years, 39% women, 74% referred vs 2003: median age 71 years, 36% women, 64% referred) and followed up through September 2010. Survival functions showed CR referral to be an independent predictor for survival in 2003, but not in 1995 (hazard ratio (HR), 0.90; 95% confidence interval [CI]; 0.70 to 1.17, p = 0.44 in 1995 vs HR, 0.80; 95% CI, 0.66 to 0.96, p = 0.02 in 2003) when patients entered the model at three months after discharge and had a common exit at 90 months. Significant positive and negative predictors for CR referral were beta-blocker prescription (+), reperfusion (+) and age (-) in 1995, and reperfusion (+), revascularization (+), heart failure (HF) (+), antiplatelets (+), angiotensin-converting-enzyme inhibitor (ACE-I) (+), statins (+), diabetes (-), and the modified Global Registry of Acute Cardiac Events (GRACE) risk score (-) in 2003.
CR referral was associated with improved survival in 2003, but not in 1995 in patients admitted with acute MI.
国际指南推荐急性心肌梗死(AMI)后进行心脏康复(CR)转诊。然而,CR转诊对长期生存的影响尚未根据时间变化进行调整。我们比较了连续两个十年中AMI住院后CR转诊的效果。
在1995年和2003年的急性冠状动脉事件评估(EMMACE)-1和2的前瞻性观察研究中,分别招募了2196例和2055例患者(1995年:中位年龄72岁,39%为女性,74%接受转诊;2003年:中位年龄71岁,36%为女性,64%接受转诊),并随访至2010年9月。生存函数显示,2003年CR转诊是生存的独立预测因素,但1995年并非如此(风险比(HR),0.90;95%置信区间[CI]:0.70至1.17,1995年p = 0.44;HR,0.80;95% CI,0.66至0.96,2003年p = 0.02),患者在出院后三个月进入模型,并在90个月时共同退出。1995年CR转诊的显著阳性和阴性预测因素分别为β受体阻滞剂处方(+)、再灌注(+)和年龄(-),2003年为再灌注(+)、血运重建(+)、心力衰竭(HF)(+)、抗血小板药物(+)、血管紧张素转换酶抑制剂(ACE-I)(+)、他汀类药物(+)、糖尿病(-)以及改良的急性心脏事件全球注册(GRACE)风险评分(-)。
2003年,急性心肌梗死入院患者中CR转诊与生存率提高相关,但1995年并非如此。